Increased synovial fluid YKL-40 levels are linked with symptomatic severity in knee osteoarthritis patients

Clinical Laboratory

Volumn 61, Issue 8, 2015, Pages 991-997

  Guan, Jian ^a   Zhang, Liu ^a,b   Li, Feng ^c   Feng, Jian Shu ^c   Wang, Hua Jun ^d   Chu, Jian Guo ^e   Song, Yong Zhou ^a   Xie, Lei ^c   Ding, Luo Bin ^c  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI UNITED UNIVERSITY   (China)

^c Department of Hand Surgery   (China)

^d THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^e Tangshan Gongren Hospital   (China)

Author keywords

Biomarker; Osteoarthritis; Symptomatic severity; YKL 40

Indexed keywords

GLYCOPROTEIN GP 39; UNCLASSIFIED DRUG; YKL 40 PROTEIN; ADIPOCYTOKINE; BIOLOGICAL MARKER; CHI3L1 PROTEIN, HUMAN; LECTIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL DISABILITY; SCORING SYSTEM; SYNOVIAL FLUID; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; AGED; BLOOD; CASE CONTROL STUDY; CHEMISTRY; CHINA; DISABILITY; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; UPREGULATION;

ADIPOKINES; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHINA; DISABILITY EVALUATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LECTINS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; UP-REGULATION;

EID: 84941660472     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2015.150135     Document Type: Article

References (27)

1. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001;44:1237-47.
2. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-56.
3. Garnero P, Delmas PD. Biomarkers in osteoarthritis. Curr Opin Rheumatol 2003;15:641-6.
4. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nature Reviews Rheumatology 2011;7:33-42.
5. Harvey S, Weisman M, O'Dell J, et al. Chondrex: new marker of joint disease. Clin Chem 1998;44:509-16.
6. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993;268:25803-10.
7. Volck B, Johansen JS, Stoltenberg M, et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis & Cartilage 2001;9:203-14.
8. Connor JR, Dodds RA, Emery JG, et al. Human cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in-situ hybridization. Osteoarthritis and Cartilage 2000;8:87-95.
9. Kawasaki M, Hasegawa Y, Kondo S, et al. Concentration and localization of YKL-40 in hip joint diseases. Journal of Rheumatology 2001;28:341-5.
10. Stokes DG, Liu G, Coimbra IB, et al. Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis. Arthritis Rheum 2002;46: 404-19.
11. Volck B, Ostergaard K, Jhansen JS, et al. The distribution of YKL-40 in osteoarthritic and normal human cartilage. Scand J Rheumatol 1999;28:171-9.
12. Connor JR, Dodds RA, Emery JG, et al. Human cartilage glycoprotein 39 (HC-gp 39) mRNA expression in adult and fetal chondrocytes, osteoblasts and osteocytes by in situ hybridization. Osteoarthr Cartil 2000;8:87-95.
13. Johansen JS, Hvolris J, Hansen M, et al. Serum YKL-40 levels in healthy children and adults: comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol 1996;35:553-9.
14. Takahashi M, Naito K, Abe M, et al. Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther 2004;6:208-12.
15. Väänänen T, Koskinen A, Paukkeri EL. YKL-40 as a Novel Factor Associated with Inflammation and Catabolic Mechanisms in Osteoarthritic Joints. Mediators Inflamm 2014;2014:215140 [Epub].
16. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-49.
17. Ackerman I. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Aust J Physiother 2009;55:213.
18. Bellamy N, Wilson C, Hendrikz J. Population-based normative values for the Western Ontario and McMaster (WOMAC) Osteoarthritis Index: part I. Semin Arthritis Rheum 2011;41:139-48.
19. Nadrian H, Moghimi N, Nadrian E, et al. Validity and reliability of the Persian versions of WOMAC Osteoarthritis Index and Lequesne Algofunctional Index. Clin Rheumatol 2012;31:1097-102.
20. Woolacott NF, Corbett MS, Rice SJ, et al. The use and reporting of WOMAC in the assessment of the benefit of physical therapies for the pain of osteoarthritis of the knee: findings from a systematic review of clinical trials. Rheumatology (Oxford) 2012;51: 1440-6.
21. Siebuhr AS1, He Y, Gudmann NS, et al. Biomarkers of cartilage and surrounding joint tissue. Biomark Med 2014;8:713-31.
22. Bonneh-Barkay D, Bissel SJ, Wang G, et al. YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor. Am J Pathol 2008;173:130-43.
23. Schiavon LL, Narciso-Schiavon JL, Carvalho Filho RJ, et al. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic heaptitis C virus infection. J Viral Hepat 2008;15:666-74.
24. Volck B, Johansen JS, Stoltenberg M, et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthr Cartil 2001;9:203-14.
25. Shao R, Hamel K, Petersen L, et al. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene 2009;28:4456-68.
26. Zivanovi S, Rackov LP, Vojvodi D, et al. Human cartilage glycoprotein 39-biomarker of joint damage in knee osteoarthritis. Int Orthop 2009;33:1165-70.
27. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957;16:494-502.